Beck-Fahrner syndrome is an autosomal dominant disorder with mutations in the catalytic domain to reduce TET3 enzymatic activity (Beck et al., 2020; Fahrner, 2023). The gene discussed is TET3; the disease is Beck-Fahrner syndrome.